Treatment of genital warts with cryotherapy and garlic extract

Phase 3

• Conditions: Genital Wart.; Anogenital (venereal) warts; A63.0

• Registration Number: IRCT20151123025202N20
• Lead Sponsor: Hamedan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 8 March 2022

Recruitment & Eligibility

• Status: Pending
• Sex: Female
• Target Recruitment: 100

Inclusion Criteria

Genital warts (vulva, vagina and pubis)
No history of treatment in the last 6 months

Exclusion Criteria

Having underlying diseases (atopy, diabetes, hypertension, ischemic heart disease, history of heart attack or stroke, chronic kidney disease)
Taking immunosuppressive drugs
Congenital or acquired immunodeficiency

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
esion recovery rate. Timepoint: Before treatment and every 15 days after treatment for 8 weeks. Method of measurement: Clinical examination and observation, Scoring based on Ordinal scale: poor moderate good.

Secondary Outcome Measures

Name	Time	Method
Duration of treatment. Timepoint: Once every 15 days for 8 weeks. Method of measurement: Clinical examination.;Side effects of treatment. Timepoint: Once every 15 days for 8 weeks. Method of measurement: Clinical examination and questioning of the patient.